|
Naltrexone Impurity 13
|
纳曲酮杂质13
|
1201-90-7
|
|
Edaravone Impurity 7
|
依达拉奉杂质7
|
|
|
Edaravone Impurity 5
|
依达拉奉杂质5
|
|
|
Vonorasone impurity 4
|
伏诺拉生杂质4
|
|
|
Itraconazole System Suitability Mixture
|
伊曲康唑系统适用性混合物（指定 USP货号1354262）
|
|
|
Pramipexole Impurity 77
|
普拉克索杂质77
|
87976-86-1
|
|
Pegylated phosphatidylethanolamine
|
培化磷脂酰乙醇胺
|
147867-65-0
|
|
Azithromycin for system suitability CRS (designated brand EP cat. No. y0000641)
|
阿奇霉素用于系统适用性CRS(指定品牌EP 货号Y0000641）
|
|
|
Abiraterone system suitability mix (designated brand USP 1000829)
|
阿比特龙系统适用性混合物（指定品牌USP 1000829）
|
|
|
Entecavir (R,R,S)-Isomer Hydrate
|
恩替卡韦-(R,R,S)-异构体-水合物（恩替卡韦杂质72）
|
|
|
Entecavir Impurity 73
|
恩替卡韦杂质73
|
|
|
Chondroitin sulfate sodium CRS(Designated brand EP Y0000280)
|
硫酸软骨素钠CRS(指定品牌EP Y0000280)
|
|
|
Lead solution CRS (designated brand EP Y0001996)
|
铅溶液CRS(指定品牌EP Y0001996)
|
|
|
Edaravone Impurity 2
|
依达拉奉杂质2
|
674-82-8
|
|
Beclometasone Propionate EP Impurity C
|
丙酸倍氯米松EP杂质C
|
|
|
Beclomethasone propionate EP system suitability control article (designated brand EDQM y0000352)
|
丙酸倍氯米松EP系统适用性对照品（指定品牌EDQM Y0000352)
|
|
|
Landiolol Impurity 33
|
兰地洛尔杂质33
|
2180628-04-8
|
|
Theophylline Impurity 11
|
茶碱杂质11
|
39726-70-0
|
|
Landiolol Impurity 31
|
兰地洛尔杂质31
|
|
|
Lactulose impurity 5
|
乳果糖杂质5
|
|
|
Clopidogrel impurity A
|
氯吡格雷杂质A(指定EP货号Y0001335）
|
|
|
Theophylline Impurity 9
|
茶碱杂质9
|
42772-85-0
|
|
Moxifloxacin Impurity 92
|
莫西沙星杂质92
|
557-66-4
|
|
Beclomethasone propionate EP peak discrimination control (assigned brand EDQM y0000469)
|
丙酸倍氯米松EP峰鉴别对照品（指定品牌EDQM Y0000469)
|
|
|
Beclomethasone dipropionate impurities F and n (designated brand EP cat. No. y0001073)
|
二丙酸倍氯米松杂质F和N（指定品牌EP 货号Y0001073）
|
|
|
Brinzolamide impurity 3
|
布林佐胺杂质3
|
308358-88-5
|
|
Vigabatrin USP related impurity E (specify brand USB cat. No. 1712045)
|
氨己烯酸USP有关杂质E（指定品牌USB 货号1712045）
|
|
|
Cinnarizine Impurity 65
|
西替利嗪杂质65
|
2705552-48-1
|
|
Morpholinonitrazole impurity 5
|
吗啉硝唑杂质5
|
2213449-45-5
|
|
Ornidazole Impurity 24
|
奥硝唑杂质24
|
|
|
Ornidazole Impurity 26
|
奥硝唑杂质26
|
|
|
Ornidazole Impurity 25
|
奥硝唑杂质25
|
|
|
Morpholinonitrazole impurity 6
|
吗啉硝唑杂质6
|
1782143-94-5
|
|
Indatrol Impurity 3
|
茚达特罗杂质3
|
|
|
Cabergoline Impurity 24
|
卡麦角林杂质24
|
591-87-7
|
|
Bumetanide Impurity 26
|
布美他尼杂质26
|
|
|
Tofatinib Impurity 40
|
托法替尼杂质40
|
|
|
Fluticasone Furoate Impurity 9
|
糠酸氟替卡松杂质9
|
|
|
Fluticasone Furoate Impurity 10
|
糠酸氟替卡松杂质10
|
11111-34-5
|
|
Fluticasone Furoate Impurity 8
|
糠酸氟替卡松杂质8
|
|
|
Bumetanide Impurity 25
|
布美他尼杂质25
|
|
|
Bumetanide Impurity 22
|
布美他尼杂质22
|
|
|
Prednisolone Phosphate USP Impurity E
|
磷酸泼尼松龙USP杂质E
|
|
|
Rosuvastatin calcium (designated brand USP cat. No. 1606015
|
瑞舒伐他汀钙（指定品牌USP 货号1606015
|
|
|
Fingolimod system suitability mix (designated brand USP cat. No. 1270526
|
芬戈莫德系统适用性混合物（指定品牌 USP货号1270526
|
|
|
Adapalene control article (designated brand USP cat. No. 1011709
|
阿达帕林对照品（指定品牌USP 货号1011709
|
|
|
Moxifloxacin peak discrimination (bedqm cat. No. y0002081)
|
莫西沙星峰鉴别（BEDQM 货号Y0002081）
|
|
|
Ketoconazole Impurity 28
|
酮康唑杂质28
|
|
|
Sofosbuvir Impurity 32
|
索非布韦杂质32
|
1157884-58-6
|
|
Escitalopram system suitability (assigned brand EDQM cat. No. y0001797)
|
艾司西酞普兰系统适用性（指定品牌 EDQM 货号Y0001797）
|
|
|
Citalopram r-oxalate (designated brand USP cat. No. 1134142)
|
R-草酸西酞普兰（指定品牌USP 货号1134142）
|
|
|
Ketoconazole Impurity 29
|
酮康唑杂质29
|
133345-21-8
|
|
Salicylic acid tablets standard (designated brand: Chinese Academy cat. No: 100103)
|
水杨酸片标准品(指定品牌：中检院 货号：100103）
|
|
|
Lansoprazole impurity II (specified brand: Chinese Academy cat. No: 510047)
|
兰索拉唑杂质Ⅱ(指定品牌：中检院 货号：510047）
|
|
|
Carbazochrome Sodium Sulfonate Impurity 30
|
卡络磺钠杂质30
|
|
|
Avibatan genotoxic Impurity 1
|
阿维巴坦基因毒杂质1
|
|
|
Methotrexate Impurity 26
|
甲氨蝶呤杂质26
|
|
|
Methotrexate EP Impurity G
|
甲氨蝶呤EP杂质G
|
2519848-42-9
|
|
Avibatan genotoxic Impurity 3
|
阿维巴坦基因毒杂质3
|
|
|
Tranexamic acid impurity standard
|
氨甲环酸杂质标准（指定品牌BP 货号734）
|
|
|
Estradiol valerate impurity 10
|
戊酸雌二醇杂质10
|
|
|
Ofloxacin impurity E
|
氧氟沙星杂质E （货号O0120050）
|
|
|
Avibatan genotoxic Impurity 2
|
阿维巴坦基因毒杂质2
|
|
|
Benhexol impurity 14
|
苯海索杂质14
|
|
|
Timolol EP Impurity J
|
噻吗洛尔EP杂质J
|
|
|
Benhexol impurity 13
|
苯海索杂质13
|
|
|
Relugolix Impurity 15
|
瑞卢戈利杂质15
|
|
|
Drotaverine Impurity 13
|
屈他维林杂质13
|
|
|
Drotaverine Impurity 27
|
屈他维林杂质27
|
|
|
Drotaverine Impurity 28
|
屈他维林杂质28(氮氧化物）
|
|
|
Drotaverine Impurity 26
|
屈他维林杂质26
|
|
|
Drotaverine Impurity 23
|
屈他维林杂质23
|
|
|
Drotaverine Impurity 25
|
屈他维林杂质25
|
|
|
Vigabatrin Impurity 18
|
氨己烯酸杂质18
|
|
|
Gefitinib Impurity 69
|
吉非替尼杂质69
|
|
|
Montelukast methanol impurities1
|
孟鲁司特酮甲醇杂质1（指定TLC货号?M-3014）
|
|
|
Montelukast dicyclohexylamine
|
孟鲁司特二环己胺（指定EP 货号Y0001436）
|
|
|
Ibuprofen Impurity 69(mixture)
|
布洛芬杂质69（混合物）
|
|
|
Moxonidine adulterant(Impuriy) A
|
莫索尼定掺杂物(杂质）（指定品牌EP Y0000222)
|
|
|
Nimesulide impurity D (control article)
|
尼美舒利杂质D(对照品)（指定EP货号：N0845008）
|
|
|
Siliconized microcrystalline cellulose
|
硅化微晶纤维素（指定USP货号：1098399）
|
|
|
Lilalitine impurity 1
|
利拉利汀杂质1
|
|
|
Omeprazole Related Compound F and G Mixture
|
奥美拉唑相关物质F和G混合物 （货号1478491）
|
|
|
Vilanterol Impurity 44
|
维兰特罗杂质44
|
24085-19-6
|
|
Fluconazole triazole ethyl impurity
|
氟康唑三唑乙基杂质(氟康唑杂质25)
|
|
|
Bumetanide Impurity 23
|
布美他尼杂质23
|
|
|
Bumetanide Impurity 24
|
布美他尼杂质24
|
|
|
8s-isopropyl-3β-hydroxytropanium bromide
|
8s-异丙基-3β-羟基托烷溴化物（指定BP货号626）
|
|
|
Phenylhexol impurity 4
|
苯海索杂质4
|
|
|
Molnupiravir Impurity 17
|
莫那匹韦杂质17
|
|
|
Fenoterol system suitability CRS
|
非诺特罗系统适用性CRS（指定品牌EP Y0002102）
|
|
|
Molnupiravir Impurity 19
|
莫那匹韦杂质19
|
|
|
Molnupiravir Impurity 21
|
莫那匹韦杂质21
|
|
|
Molnupiravir Impurity 16
|
莫那匹韦杂质16
|
2346620-53-7
|
|
Fusidic Acid EP Impurity B
|
夫西地酸EP杂质B
|
|
|
Famotidine Impurity 26
|
法莫替丁杂质26
|
95853-46-6
|
|
Vitamin B2 impurity 3
|
维生素B2杂质3
|
64480-68-8
|
|
Lurasislone Impurity 18
|
鲁拉西酮杂质18
|
1807983-62-5
|
|
Vitamin B2 impurity 1
|
维生素B2杂质1
|
|
|
Phenylhexol impurity 8
|
苯海索杂质8
|
127865-20-7
|